When was Cardio Diagnostics founded?

Cardio Diagnostics was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Where is Cardio Diagnostics located?

Cardio Diagnostics is headquartered in Chicago, United States.

Who is the current CEO of Cardio Diagnostics?

Meesha Dogan of Cardio Diagnostics. They have also founded 1 company.

How many employees does Cardio Diagnostics have?

As of Mar 31, 2026, the latest employee count at Cardio Diagnostics is 31.

Is Cardio Diagnostics a funded company?

Cardio Diagnostics is a funded company, having raised an undisclosed amount across 4 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on May 17, 2022.

When was the latest funding round of Cardio Diagnostics?

Cardio Diagnostics' latest funding was a $***** Post IPO round on Feb 02, 2024, with participation from 0 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $2.96B in funding in 2026 to date.

What is the annual revenue of Cardio Diagnostics?

Annual revenue of Cardio Diagnostics is $14.8K as on Dec 31, 2025.

Where does Cardio Diagnostics rank among its competitors?

Cardio Diagnostics ranks 18th amongst 56 active competitors, of which 18 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was HeartIO, which secured $4.25M in Mar, 2026.

Who are the top competitors of Cardio Diagnostics?

Cardio Diagnostics' top competitors include HeartFocus, Powerful Medical and Laza Medical. Among them, HeartIO secured the most recent funding round in March, 2026.

Cardio Diagnostics - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

AI based platform offering cardiovascular medicine. It provides solutions for heart attack risk assessment, heart disease prevention, and management. The platform utilizes genetic epigenetic technology to identify risk factors and provide personalized recommendations for patients. It It provideds various solutions such as epigenetics CHD test, precisionCHD test, and more. It integrates test results with patient specific data to provide actionable insights for healthcare professionals.

Website: cdio.ai
Social
Email ID: *****@cardiodiagnosticsinc.com

Key Metrics

Founded Year

2017

Location

Chicago, United States

Stage

Public

Latest Funding Round

Post IPO, Feb 02, 2024, $*****

Investors

Yorkville Advisors

Ranked

18^th among 56 active competitors

Annual Revenue

$14.8K as on Dec 31, 2025

Employee Count

31 as on Mar 31, 2026

Similar Companies

HeartFocus & 59 more

Exit Details

Public

View Cardio Diagnostics' full profile

Cardio Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CARDIO DIAGNOSTICS HOLDINGS, INC. CIN: 1870144 , United States, Active		$14.8K (As on Dec 31, 2025)	-	-

Cardio Diagnostics got listed on Jan 14, 2022.

Click here to take a look at Cardio Diagnostics's IPO in detail

Cardio Diagnostics has raised funding over 4 rounds. Its first funding round was on May 17, 2022. Cardio Diagnostics has 1 institutional investor.

Here is the list of recent funding rounds of Cardio Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 02, 2024	6142552	Post IPO	2913776	3388088	2458290	2979378
Mar 09, 2023	7796215	Post IPO	2107952	4303843	1967728	Yorkville Advisors
Oct 04, 2022	7539682	Post IPO	7153852	1742526	6662546	3161084

Access funding benchmarks and valuations. Sign up today!

View details of Cardio Diagnostics's funding rounds and investors

The founders of Cardio Diagnostics are Robert Philibert and Meesha Dogan. Meesha Dogan is the CEO of Cardio Diagnostics.

Here are the details of Cardio Diagnostics' key team members:

Robert Philibert: Co-Founder of Cardio Diagnostics and founder of 1 other company.
Contact Info: 2 email addresses
Meesha Dogan: CEO, Founder & Board Member of Cardio Diagnostics.

View details of Cardio Diagnostics's Founder profiles and Board Members

Cardio Diagnostics' employee count trend

Cardio Diagnostics has 31 employees as of Mar 26. Here is Cardio Diagnostics's employee count trend over the years:

Employee count trend for Cardio Diagnostics

Uncover Cardio Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cardio Diagnostics include HeartFocus, Powerful Medical and Laza Medical. Here is the list of Top 10 competitors of Cardio Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	HeartFocus 2023, Bordeaux (France), Seed	AI-driven app for healthcare professionals to perform cardiac ultrasound exams	$6M	Racine², BNP Paribas Developpement & 4 others	63/100
2nd	Powerful Medical 2019, Bratislava (Slovakia), Series A	Developer of AI-powered platform for interpreting electrocardiograms and detecting heart conditions	$11.4M	Venture to Future Fund, Europa & 6 others	59/100
3rd	Laza Medical 2022, Los Gatos (United States), Series A	AI-powered robotically-assisted imaging solutions for cardiovascular interventions	$36M	The Capital Partnership, Shifamed & 5 others	56/100
4th	Volta Medical 2016, Marseille (France), Series B	AI-based software developer for providing cardiac mapping assistance tools	$74.2M	Gilde Healthcare, Vensana Capital & 2 others	56/100
5th	CorVista 2012, Toronto (Canada), Series C	Provider of an AI-based cardiac health diagnosis tool for healthcare professionals	$179M	G Ventures, Bioworld Ventures & 2 others	56/100
6th	Keya Medical 2016, Seattle (United States), Series C	Provider of AI-based diagnosis tools for cardiologists	$30.2M	IDG Capital, Source Code Capital & 4 others	51/100
7th	VahatiCor 2021, Santa Clara (United States), Series B	Platform offering solutions on addressing coronary microvascular disease	$23M	S3 Ventures, Intuitive Ventures	51/100
8th	Cardio Intelligence 2019, Minato City (Japan), Series B	AI-based medical devices for diagnosis and treatment of heart diseases	$3.22M	Shizuoka Bank, SMBC Venture Capital & 6 others	46/100
9th	HeartIO 2019, Pittsburgh (United States), Seed	Provider of AI-based platform for the diagnosis of heart abnormalities	$4.45M	Bessel, VU Venture Partners & 3 others	46/100
10th	Forest Devices 2015, Pittsburgh (United States), Seed	Provider of a stroke screening device for medical personnel in outpatient clinics	$6.33M	GOOSE Capital, Pittsburgh Life Sciences Greenhouse ... & 14 others	46/100
18th	Cardio Diagnostics 2017, Chicago (United States), Public	AI based platform offering cardiovascular medicine	-	Yorkville Advisors	37/100